(Q58197587)

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

ABCA1-deficient mice: insights into the role of monocyte lipid efflux in HDL formation and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Natural regulatory T cells control the development of atherosclerosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Recent advances on the role of cytokines in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Theodore Cooper Memorial Lecture. Hypertension and the pathogenesis of atherosclerosis. Oxidative stress and the mediation of arterial inflammatory response: a new perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Effect of 1-year anti-TNF-α therapy on aortic stiffness, carotid atherosclerosis, and calprotectin in inflammatory arthropathies: a controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Statins reduce interleukin-6-induced C-reactive protein in human hepatocytes: new evidence for direct antiinflammatory effects of statins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Comparison of Efficacy and Safety of Rosuvastatin, Atorvastatin and Pravastatin among Dyslipidemic Diabetic Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

TGF-beta-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Elevated ICAM-1 and MCP-1 plasma levels in subjects at high cardiovascular risk are diminished by atorvastatin treatment. Atorvastatin on Inflammatory Markers study: a substudy of Achieve Cholesterol Targets Fast with Atorvastatin Stratified Titrati

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

12/15-lipoxygenase regulates intercellular adhesion molecule-1 expression and monocyte adhesion to endothelium through activation of RhoA and nuclear factor-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

12/15 lipoxygenase mediates monocyte adhesion to aortic endothelium in apolipoprotein E-deficient mice through activation of RhoA and NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Identification of the low density lipoprotein receptor-binding site in apolipoprotein B100 and the modulation of its binding activity by the carboxyl terminus in familial defective apo-B100.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Identification of the principal proteoglycan-binding site in LDL. A single-point mutation in apo-B100 severely affects proteoglycan interaction without affecting LDL receptor binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Statins and blood pressure regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Inhibition of tumor necrosis factor-alpha reduces atherosclerosis in apolipoprotein E knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Chemokine CCL5/RANTES inhibition reduces myocardial reperfusion injury in atherosclerotic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Influence of interferon-gamma on the extent and phenotype of diet-induced atherosclerosis in the LDLR-deficient mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Enhancement of lipopolysaccharide-induced toll-like receptor 2 expression and inflammatory cytokine secretion in HUVECs under high glucose conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Statin inhibits interferon-gamma-induced expression of intercellular adhesion molecule-1 (ICAM-1) in vascular endothelial and smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Apoptosis of vascular smooth muscle cells induces features of plaque vulnerability in atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

P-Selectin or intercellular adhesion molecule (ICAM)-1 deficiency substantially protects against atherosclerosis in apolipoprotein E-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Treatment with Evasin-3 reduces atherosclerotic vulnerability for ischemic stroke, but not brain injury in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

T and B lymphocytes play a minor role in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Chemokines CCL3/MIP1α, CCL5/RANTES and CCL18/PARC are independent risk predictors of short-term mortality in patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Ticks produce highly selective chemokine binding proteins with antiinflammatory activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Monocyte chemoattractant protein-1 (MCP-1): an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Intima-media thickness evolution after treatment with infliximab in patients with rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

The combined role of P- and E-selectins in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Auto-Antigenic Protein-DNA Complexes Stimulate Plasmacytoid Dendritic Cells to Promote Atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Reprogramming of the macrophage transcriptome in response to interferon-gamma and Mycobacterium tuberculosis: signaling roles of nitric oxide synthase-2 and phagocyte oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Mechanisms of monocyte recruitment and accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Mouse models of hyperlipidemia and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Hydroxy-methylglutaryl-coenzyme A reductase inhibition promotes endothelial nitric oxide synthase activation through a decrease in caveolin abundance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Endothelial cell signaling and endothelial dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Molecular cloning and characterization of a highly selective chemokine-binding protein from the tick Rhipicephalus sanguineus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Comparative effectiveness of antihypertensive medication for primary prevention of cardiovascular disease: systematic review and multiple treatments meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Vascular and epithelial junctions: a barrier for leucocyte migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

12/15-Lipoxygenase gene disruption attenuates atherogenesis in LDL receptor-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Chemokines, leukocytes, and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Animal models of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Efficacy, safety, and tolerability of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 in combination with a statin in patients with hypercholesterolaemia (LAPLACE-TIMI 57): a randomised, placebo-controlled, dose-ranging, phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Atherosclerosis. the road ahead

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Specific abrogation of transforming growth factor-beta signaling in T cells alters atherosclerotic lesion size and composition in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Major risk factors as antecedents of fatal and nonfatal coronary heart disease events

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

IFN-gamma potentiates atherosclerosis in ApoE knock-out mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

85-kDa cPLA(2) plays a critical role in PPAR-mediated gene transcription in human hepatoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Interleukin-10 facilitates both cholesterol uptake and efflux in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Immune mechanisms in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Inflammation, atherosclerosis, and coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

The immune response in atherosclerosis: a double-edged sword

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Interferon-gamma and atherosclerosis: pro- or anti-atherogenic?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Oral antiplatelet therapy in secondary prevention of cardiovascular events: an assessment from the payer's perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Regulatory T-Cell Response to Apolipoprotein B100–Derived Peptides Reduces the Development and Progression of Atherosclerosis in Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Structure of low density lipoprotein (LDL) particles: basis for understanding molecular changes in modified LDL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Heparin-binding EGF-like growth factor stimulation of smooth muscle cell migration: dependence on interactions with cell surface heparan sulfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Alpha(1,3)fucosyltransferases FucT-IV and FucT-VII control susceptibility to atherosclerosis in apolipoprotein E-/- mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

T helper-cell phenotype regulates atherosclerosis in mice under conditions of mild hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

P-selectin glycoprotein ligand-1 plays a crucial role in the selective recruitment of leukocytes into the atherosclerotic arterial wall.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Regulation of vascular cell adhesion molecule-1 expression by IL-4 and TNF-alpha in cultured endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Adhesion mechanisms regulating the migration of monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Effects of pitavastatin on adiponectin in patients with hyperlipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Methylation of FOXP3 in regulatory T cells is related to the severity of coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Insights into cyclosporine A-induced atherosclerotic risk in transplant recipients: macrophage scavenger receptor regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

LXRs: new therapeutic targets in atherosclerosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Molecular interactions leading to lipoprotein retention and the initiation of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Role of hsp60 during autoimmune and bacterial inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Interleukin-4 deficiency decreases atherosclerotic lesion formation in a site-specific manner in female LDL receptor-/- mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Inflammation, statin therapy, and risk of stroke after an acute coronary syndrome in the MIRACL study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Genetic modifiers of atherosclerosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Chemokines: established and novel targets in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Absence of CD36 protects against atherosclerosis in ApoE knock-out mice with no additional protection provided by absence of scavenger receptor A I/II

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Atherosclerosis: anti-inflammatory and immunomodulatory activities of statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Transcriptional repression of atherogenic inflammation: modulation by PPARdelta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Gamma interferon: a central mediator in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Changing concepts of atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

A New Monocyte Chemotactic Protein-1/Chemokine CC Motif Ligand-2 Competitor Limiting Neointima Formation and Myocardial Ischemia/Reperfusion Injury in Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Abrogated transforming growth factor beta receptor II (TGFβRII) signalling in dendritic cells promotes immune reactivity of T cells resulting in enhanced atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

PPARgamma activation induces CD36 expression and stimulates foam cell like changes in rVSMCs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Cyclosporin variably and inconsistently reduces infarct size in experimental models of reperfused myocardial infarction: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

C-reactive protein induces TNF-α secretion by p38 MAPK-TLR4 signal pathway in rat vascular smooth muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Both early and delayed anti-CD40L antibody treatment induces a stable plaque phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Requirement for CD154 in the progression of atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Atorvastatin has an important acute anti-inflammatory effect in patients with acute coronary syndrome: results of a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

The effect of statins on carotid plaque morphology: a LDL-associated action or one more pleiotropic effect of statins?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Protective Role of Interleukin-10 in Atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Induction of a regulatory T cell type 1 response reduces the development of atherosclerosis in apolipoprotein E-knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Inhibition of transforming growth factor-beta signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Management of dyslipidemias in the presence of the metabolic syndrome or type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

IL-10 mediates the immunoregulatory response in conjugated linoleic acid-induced regression of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Effect of cyclosporine on left ventricular remodeling after reperfused myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Efficacy and safety of statin treatment for cardiovascular disease: a network meta-analysis of 170,255 patients from 76 randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

CC chemokine CCL5 plays a central role impacting infarct size and post-infarction heart failure in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Statins inhibit C-reactive protein-induced chemokine secretion, ICAM-1 upregulation and chemotaxis in adherent human monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Single Administration of the CXC Chemokine-Binding Protein Evasin-3 During Ischemia Prevents Myocardial Reperfusion Injury in Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Systemic and intraplaque mediators of inflammation are increased in patients symptomatic for ischemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Common inflammatory mediators orchestrate pathophysiological processes in rheumatoid arthritis and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Scavenger receptors in atherosclerosis: beyond lipid uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

LXR-activating oxysterols induce the expression of inflammatory markers in endothelial cells through LXR-independent mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Cyclosporin A enhances interleukin-8 expression by inducing activator protein-1 in human aortic smooth muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Comparative benefits of statins in the primary and secondary prevention of major coronary events and all-cause mortality: a network meta-analysis of placebo-controlled and active-comparator trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

oxLDL uptake by dendritic cells induces upregulation of scavenger-receptors, maturation and differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Pravastatin promotes coronary collateral circulation in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Endoplasmic reticulum stress controls M2 macrophage differentiation and foam cell formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

CXC chemokine KC fails to induce neutrophil infiltration and neoangiogenesis in a mouse model of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

The role of the chemokines MCP-1, GRO-alpha, IL-8 and their receptors in the adhesion of monocytic cells to human atherosclerotic plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Evaluation of VCAM-1 antibodies as therapeutic agent for atherosclerosis in apolipoprotein E-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

A role for endothelial cell lipoxygenase in the oxidative modification of low density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Protection from procedural myocardial injury by atorvastatin is associated with lower levels of adhesion molecules after percutaneous coronary intervention: results from the ARMYDA-CAMs (Atorvastatin for Reduction of MYocardial Damage during Angiopl

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Resident intimal dendritic cells accumulate lipid and contribute to the initiation of atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Cytokines release inhibition from activated monocytes, and reduction of in-stent neointimal growth in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Involvement of chemokine receptor 2 and its ligand, monocyte chemoattractant protein-1, in the development of atherosclerosis: lessons from knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Oxidative stress-mediated platelet CD40 ligand upregulation in patients with hypercholesterolemia: effect of atorvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Effect of cyclosporine on reperfusion injury in acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Atorvastatin reduces macrophage accumulation in atherosclerotic plaques: a comparison of a nonstatin-based regimen in patients undergoing carotid endarterectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Smooth muscle cells and the pathogenesis of the lesions of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Disruption of TGF-β signaling in T cells accelerates atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Atherosclerosis — An Inflammatory Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Mechanisms of dysregulation of low-density lipoprotein receptor expression in vascular smooth muscle cells by inflammatory cytokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Downregulated CD36 and oxLDL uptake and stimulated ABCA1/G1 and cholesterol efflux as anti-atherosclerotic mechanisms of interleukin-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Oral anti-CD3 antibody treatment induces regulatory T cells and inhibits the development of atherosclerosis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Importance of junctional adhesion molecule-C for neointimal hyperplasia and monocyte recruitment in atherosclerosis-prone mice-brief report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Macrophage differentiation to foam cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Atorvastatin improves left ventricular systolic function and serum markers of inflammation in nonischemic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Simvastatin has anti-inflammatory and antiatherosclerotic activities independent of plasma cholesterol lowering

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Effect of a monoclonal antibody to PCSK9 on low-density lipoprotein cholesterol levels in statin-intolerant patients: the GAUSS randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Macrophage death and defective inflammation resolution in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Interleukin-1beta attenuates beta-very low-density lipoprotein uptake and its receptor expression in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Identification of macrophage liver X receptors as inhibitors of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Reactive oxygen species and thiol redox signaling in the macrophage biology of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

PPARalpha deficiency reduces insulin resistance and atherosclerosis in apoE-null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Simvastatin modulates chemokine and chemokine receptor expression by geranylgeranyl isoprenoid pathway in human endothelial cells and macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Antagonism of RANTES receptors reduces atherosclerotic plaque formation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Protective effect of atorvastatin on acute systemic inflammation-induced endothelial dysfunction in hypercholesterolaemic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Regression of atherosclerosis plaques in apolipoprotein E-/- mice after lentivirus-mediated RNA interference of CD40.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Specific activation of leukocyte beta2 integrins lymphocyte function-associated antigen-1 and Mac-1 by chemokines mediated by distinct pathways via the alpha subunit cytoplasmic domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

CCL17-expressing dendritic cells drive atherosclerosis by restraining regulatory T cell homeostasis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

The response-to-retention hypothesis of early atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Development of the smooth muscle foam cell: uptake of macrophage lipid inclusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Understanding hyperlipidemia and atherosclerosis: lessons from genetically modified apoe and ldlr mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Interleukin-10 down-regulates oxLDL induced expression of scavenger receptor A and Bak-1 in macrophages derived from THP-1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Loss of PDZK1 causes coronary artery occlusion and myocardial infarction in Paigen diet-fed apolipoprotein E deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

The essential role of p38 MAPK in mediating the interplay of oxLDL and IL-10 in regulating endothelial cell apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Lipid homeostasis and the formation of macrophage-derived foam cells in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Animal models of cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Importance of Junctional Adhesion Molecule-A for Neointimal Lesion Formation and Infiltration in Atherosclerosis-Prone Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Chemokines in the vascular inflammatory response of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0402-8

Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month

21 January 2018

1 reference

12 December 2020

A Novel RANTES Antagonist Prevents Progression of Established Atherosclerotic Lesions in Mice

1 reference

12 December 2020

ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree

1 reference

12 December 2020

Studies of hypercholesterolemia in the nonhuman primate. I. Changes that lead to fatty streak formation

1 reference

12 December 2020

Short-term treatment with anti-CD3 antibody reduces the development and progression of atherosclerosis in mice

1 reference

12 December 2020

Association of plasma levels of F11 receptor/junctional adhesion molecule-A (F11R/JAM-A) with human atherosclerosis

1 reference

12 December 2020

Clinical review 145: Pleiotropic effects of statins: lipid reduction and beyond

1 reference

12 December 2020

Scavenger receptor family proteins: roles for atherosclerosis, host defence and disorders of the central nervous system

1 reference

12 December 2020

Enzymatically Degraded, Nonoxidized LDL Induces Human Vascular Smooth Muscle Cell Activation, Foam Cell Transformation, and Proliferation

1 reference

12 December 2020

Pathogen-sensing plasmacytoid dendritic cells stimulate cytotoxic T-cell function in the atherosclerotic plaque through interferon-alpha

1 reference

12 December 2020

The chemokine and scavenger receptor CXCL16/SR-PSOX is expressed in human vascular smooth muscle cells and is induced by interferon gamma

1 reference

12 December 2020

The role of adaptive T cell immunity in atherosclerosis

1 reference

12 December 2020

Mechanism of degradation of the steroid side chain in the formation of bile acids

1 reference

12 December 2020

Blocking very late antigen-4 integrin decreases leukocyte entry and fatty streak formation in mice fed an atherogenic diet

1 reference

12 December 2020

Foam cell formation containing lipid droplets enriched with free cholesterol by hyperlipidemic serum

1 reference

12 December 2020

The Reduction of Inflammatory Biomarkers by Statin, Fibrate, and Combination Therapy Among Diabetic Patients With Mixed Dyslipidemia

1 reference

12 December 2020

Transfer of CD4(+) T cells aggravates atherosclerosis in immunodeficient apolipoprotein E knockout mice

1 reference

12 December 2020

Increased soluble Fas plasma levels in subjects at high cardiovascular risk: Atorvastatin on Inflammatory Markers (AIM) study, a substudy of ACTFAST

1 reference

12 December 2020

Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis

1 reference

12 December 2020

Flt3 signaling-dependent dendritic cells protect against atherosclerosis

1 reference

12 December 2020

The serum concentration of active transforming growth factor-beta is severely depressed in advanced atherosclerosis

1 reference

12 December 2020

The role of interleukin 12 in the development of atherosclerosis in ApoE-deficient mice

1 reference

12 December 2020

Oxidized low-density lipoprotein promotes mature dendritic cell transition from differentiating monocyte

1 reference

12 December 2020

Macrophages, inflammation, and atherosclerosis

1 reference

12 December 2020

Cerivastatin suppresses lipopolysaccharide-induced ICAM-1 expression through inhibition of Rho GTPase in BAEC

1 reference

12 December 2020

Interleukin-10 blocks atherosclerotic events in vitro and in vivo

1 reference

12 December 2020

Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines

1 reference

12 December 2020

Oxidized low density lipoprotein (ox-LDL) binding to ox-LDL receptor-1 in endothelial cells induces the activation of NF-kappaB through an increased production of intracellular reactive oxygen species

1 reference

12 December 2020

Hypertension detection, treatment and control: a call to action for cardiovascular specialists

1 reference

12 December 2020

Statins as a newly recognized type of immunomodulator

1 reference

12 December 2020

The role of junctional adhesion molecule-C (JAM-C) in oxidized LDL-mediated leukocyte recruitment

1 reference

12 December 2020

Tumor necrosis factor-alpha antagonists improve aortic stiffness in patients with inflammatory arthropathies: a controlled study

1 reference

12 December 2020

Effects of Atorvastatin on Inflammatory and Fibrinolytic Parameters in Patients with Chronic Kidney Disease

1 reference

12 December 2020

Induction of early atherosclerosis in LDL-receptor-deficient mice immunized with beta2-glycoprotein I

1 reference

12 December 2020

Lipoprotein lipase and sphingomyelinase synergistically enhance the association of atherogenic lipoproteins with smooth muscle cells and extracellular matrix. A possible mechanism for low density lipoprotein and lipoprotein(a) retention and macropha

1 reference

12 December 2020

Statins for the primary prevention of cardiovascular disease

1 reference

12 December 2020

Direct viewing of atherosclerosis in vivo: plaque invasion by leukocytes is initiated by the endothelial selectins

1 reference

12 December 2020

Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors or angiotensin II-receptor blockers for ischemic heart disease

1 reference

12 December 2020

Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice

1 reference

12 December 2020

Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor-alpha therapy

1 reference

12 December 2020

ACE inhibition in stable coronary artery disease

1 reference

12 December 2020

Expression of macrophage (Mphi) scavenger receptor, CD36, in cultured human aortic smooth muscle cells in association with expression of peroxisome proliferator activated receptor-gamma, which regulates gain of Mphi-like phenotype in vitro, and its

1 reference

12 December 2020

Interleukin-10 deficiency increases atherosclerosis, thrombosis, and low-density lipoproteins in apolipoprotein E knockout mice.

1 reference

12 December 2020

Advances in cyclosporine pharmacology, measurement, and therapeutic monitoring

1 reference

12 December 2020

Anti-inflammatory effects of pioglitazone and/or simvastatin in high cardiovascular risk patients with elevated high sensitivity C-reactive protein: the PIOSTAT Study

1 reference

12 December 2020

Lipoxygenase pathways as mediators of early inflammatory events in atherosclerosis

1 reference

12 December 2020

Shear stress-stimulated endothelial cells induce smooth muscle cell chemotaxis via platelet-derived growth factor-BB and interleukin-1alpha

1 reference

12 December 2020

Interleukin-17A Deficiency Accelerates Unstable Atherosclerotic Plaque Formation in Apolipoprotein E-Deficient Mice

1 reference

12 December 2020